Capivasertib 160 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 160 mg

Reference Brands: Truqap (USA)

Category: Oncology Cancer Care

Capivasertib is a Oncology Cancer Care product available as Tablets in strengths 160 mg. It corresponds to the reference brand Truqap (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Capivasertib, also known by the brand name Truqap, is an oral targeted anticancer therapy used in combination with fulvestrant for the treatment of adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It is specifically indicated for patients whose disease has progressed during or after prior hormone therapy and who have genetic alterations in the PIK3CA, AKT1, or PTEN genes.

Capivasertib works by selectively inhibiting AKT, a key protein involved in cell signaling pathways that regulate cancer cell growth, survival, and metabolism. By blocking AKT activity, capivasertib disrupts these pathways, helping to slow tumor growth and potentially induce cancer cell death. It belongs to the class of kinase inhibitors and represents an important advancement in precision oncology.

The drug is administered orally under specialist supervision and is being actively studied for use in other cancer types where AKT pathway abnormalities play a role. Capivasertib’s targeted mechanism allows for a more personalized treatment approach, offering improved outcomes for patients with specific molecular profiles while supporting long-term disease control in advanced breast cancer.